Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide.
Yi Lisa HwaMartha Q LacyMorie A GertzShaji K KumarEli MuchtarFrancis K BuadiDavid DingliNelson LeungPrashant KapoorRonald S GoMiriam A HobbsAmie L FonderWilson I GonsalvesRahma WarsameTaxiarchis V KourelisSusanne R HaymanMustaqeem A SiddiquiS Vincent RajkumarAngela DispenzieriPublished in: European journal of haematology (2021)
There is emerging evidences in recent years to suggest antitumor benefits of beta blockers (BB). BB has been explored, both in vitro and in vivo, and found to have antineoplastic effect in a variety type of cancer1-11 We have previously reported our findings that BB improved overall survival (OS) and reduced myeloma specific death.